These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 16088951

  • 1. Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2(high) and D3(high) receptors.
    Seeman P, Ko F, Willeit M, McCormick P, Ginovart N.
    Synapse; 2005 Nov; 58(2):122-8. PubMed ID: 16088951
    [Abstract] [Full Text] [Related]

  • 2. Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2(High) receptors.
    Seeman P.
    Synapse; 2007 Dec; 61(12):1013-8. PubMed ID: 17853435
    [Abstract] [Full Text] [Related]

  • 3. Dopamine receptors labelled by PHNO.
    Seeman P, Ulpian C, Larsen RD, Anderson PS.
    Synapse; 1993 Aug; 14(4):254-62. PubMed ID: 7902615
    [Abstract] [Full Text] [Related]

  • 4. In vivo characterization of the pharmacokinetics and pharmacological properties of [11C]-(+)-PHNO in rats using an intracerebral beta-sensitive system.
    Galineau L, Wilson AA, Garcia A, Houle S, Kapur S, Ginovart N.
    Synapse; 2006 Aug; 60(2):172-83. PubMed ID: 16715499
    [Abstract] [Full Text] [Related]

  • 5. High affinity binding for pramipexole, a dopamine D3 receptor ligand, in rat striatum.
    Piercey MF, Walker EL, Feldpausch DL, Camacho-Ochoa M.
    Neurosci Lett; 1996 Nov 22; 219(2):138-40. PubMed ID: 8971799
    [Abstract] [Full Text] [Related]

  • 6. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
    Peng T, Zysk J, Dorff P, Elmore CS, Ström P, Malmquist J, Ding M, Tuke D, Werkheiser J, Widzowski D, Mrzljak L, Maier D.
    Synapse; 2010 Aug 22; 64(8):624-33. PubMed ID: 20340171
    [Abstract] [Full Text] [Related]

  • 7. Glutamate receptor mGlu2 and mGlu3 knockout striata are dopamine supersensitive, with elevated D2(High) receptors and marked supersensitivity to the dopamine agonist (+)PHNO.
    Seeman P, Battaglia G, Corti C, Corsi M, Bruno V.
    Synapse; 2009 Mar 22; 63(3):247-51. PubMed ID: 19084908
    [Abstract] [Full Text] [Related]

  • 8. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
    Narendran R, Slifstein M, Guillin O, Hwang Y, Hwang DR, Scher E, Reeder S, Rabiner E, Laruelle M.
    Synapse; 2006 Dec 01; 60(7):485-95. PubMed ID: 16952157
    [Abstract] [Full Text] [Related]

  • 9. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J, Makkai B, Gulyás B, Hall H.
    Eur J Neurosci; 2005 Jul 01; 22(1):65-71. PubMed ID: 16029196
    [Abstract] [Full Text] [Related]

  • 10. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist.
    Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC.
    Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660
    [Abstract] [Full Text] [Related]

  • 11. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
    Pugsley TA, Davis MD, Akunne HC, MacKenzie RG, Shih YH, Damsma G, Wikstrom H, Whetzel SZ, Georgic LM, Cooke LW.
    J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1355-66. PubMed ID: 8531103
    [Abstract] [Full Text] [Related]

  • 12. [3H]Pramipexole: a selective radioligand for the high affinity dopamine D2 receptor in bovine striatal membranes.
    Ohnmacht U, Tränkle C, Mohr K, Gmeiner P.
    Pharmazie; 1999 Apr 15; 54(4):294-7. PubMed ID: 10234741
    [Abstract] [Full Text] [Related]

  • 13. Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo.
    McCormick PN, Kapur S, Seeman P, Wilson AA.
    Nucl Med Biol; 2008 Jan 15; 35(1):11-7. PubMed ID: 18158938
    [Abstract] [Full Text] [Related]

  • 14. Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors.
    Seeman P, Guan HC.
    Synapse; 2009 Aug 15; 63(8):705-9. PubMed ID: 19391149
    [Abstract] [Full Text] [Related]

  • 15. Nafadotride, a potent preferential dopamine D3 receptor antagonist, activates locomotion in rodents.
    Sautel F, Griffon N, Sokoloff P, Schwartz JC, Launay C, Simon P, Costentin J, Schoenfelder A, Garrido F, Mann A.
    J Pharmacol Exp Ther; 1995 Dec 15; 275(3):1239-46. PubMed ID: 8531087
    [Abstract] [Full Text] [Related]

  • 16. [3H]-quinelorane binds to D2 and D3 dopamine receptors in the rat brain.
    Gackenheimer SL, Schaus JM, Gehlert DR.
    J Pharmacol Exp Ther; 1995 Sep 15; 274(3):1558-65. PubMed ID: 7562534
    [Abstract] [Full Text] [Related]

  • 17. Dopamine D2High receptors measured ex vivo are elevated in amphetamine-sensitized animals.
    Seeman P.
    Synapse; 2009 Mar 15; 63(3):186-92. PubMed ID: 19086090
    [Abstract] [Full Text] [Related]

  • 18. Expression and pharmacological characterization of the human D3 dopamine receptor.
    Freedman SB, Patel S, Marwood R, Emms F, Seabrook GR, Knowles MR, McAllister G.
    J Pharmacol Exp Ther; 1994 Jan 15; 268(1):417-26. PubMed ID: 8301582
    [Abstract] [Full Text] [Related]

  • 19. Differential induction of adenylyl cyclase supersensitivity by antiparkinson drugs acting as agonists at dopamine D1/D2/D3 receptors vs D2/D3 receptors only: parallel observations from co-transfected human and native cerebral receptors.
    Aloisi G, Silvano E, Rossi M, Millan MJ, Maggio R.
    Neuropharmacology; 2011 Jan 15; 60(2-3):439-45. PubMed ID: 21035472
    [Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B, Horti F, Bobok A.
    Synapse; 2011 Jun 15; 65(6):467-78. PubMed ID: 20936685
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.